Cargando…

Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis

Anti-melanoma differentiation-associated protein 5 (MDA5) antibody-positive dermatomyositis (MDA5-DM) is frequently complicated with rapidly progressive-interstitial lung disease (RP-ILD). The prognosis of MDA5-DM with RP-ILD is mostly poor despite intensive treatment with a combination of high-dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Ida, Tomoaki, Furuta, Shunsuke, Takayama, Asuka, Tamura, Jun, Hayashi, Yuki, Abe, Kazuya, Kurihara, Syunjiro, Ishikawa, Junichi, Iwamoto, Taro, Ikeda, Kei, Suzuki, Kotaro, Nakajima, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809321/
https://www.ncbi.nlm.nih.gov/pubmed/36593080
http://dx.doi.org/10.1136/rmdopen-2022-002795